rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1996-1-11
|
pubmed:abstractText |
To study if placebo-induced improvement in men with symptomatic benign prostatic hyperplasia (BPH) is maintained over 2 years, and to study the efficacy and safety from intervention with finasteride 5 mg for 24 months.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0090-4295
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
631-7
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:7495111-Aged,
pubmed-meshheading:7495111-Aged, 80 and over,
pubmed-meshheading:7495111-Double-Blind Method,
pubmed-meshheading:7495111-Enzyme Inhibitors,
pubmed-meshheading:7495111-Finasteride,
pubmed-meshheading:7495111-Humans,
pubmed-meshheading:7495111-Male,
pubmed-meshheading:7495111-Middle Aged,
pubmed-meshheading:7495111-Prostatic Hyperplasia,
pubmed-meshheading:7495111-Remission Induction
|
pubmed:year |
1995
|
pubmed:articleTitle |
Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group.
|
pubmed:affiliation |
Department of Urology, Hvidovre Hospital, University of Copenhagen, Denmark.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Controlled Clinical Trial,
Multicenter Study
|